nitroblue tetrazolium has been researched along with Graft vs Host Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baume, D; Bayssas, M; Blaise, D; Fossat, C; Juhan Vague, I; Maraninchi, D; Sainty, D; Stoppa, AM; Viens, P | 1 |
1 other study(ies) available for nitroblue tetrazolium and Graft vs Host Disease
| Article | Year |
|---|---|
In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host disease.
Topics: Adult; Bone Marrow Transplantation; Cell Adhesion; Chemotaxis, Leukocyte; Female; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Humans; Neutrophils; Nitroblue Tetrazolium; Phagocytosis; Recombinant Proteins | 1993 |